Yu Fenggang, Qi Guoming, Liu Yanqing, Gao Shouyi, Kan Biao
National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing 102206, People's Republic of China.
Mol Biotechnol. 2005 Mar;29(3):191-6. doi: 10.1385/MB:29:3:191.
A naturally cholera toxin gene negative Vibrio cholerae (O1, El Tor, Ogawa) strain, named IEM101, was isolated in China. The human volunteer tests showed that this strain was safe, able to colonize the intestinal mucosa, and able to induce a strong immune response. Also other studies indicated that it was an efficient live vector to deliver heterologous antigens. In this article, a thymidylate synthase gene (thyA)-defined mutant was constructed using homologous recombination. Except for the morphological changes in minimal medium and slightly reduced colonization capacity, mutant strain IEM101-T maintained most of the desirable features as the wild-type strain IEM101 in terms of growth rate and immunogenicity. However, the mutant was more biosafe than its parent strain. In conclusion, IEM101-T may be a promising strain to develop live vaccine candidate of cholera or an attractive vaccine vector to deliver heterologous antigens in vivo.
在中国分离出了一株天然霍乱毒素基因阴性的霍乱弧菌(O1群,埃尔托生物型,小川型)菌株,命名为IEM101。人体志愿者试验表明,该菌株是安全的,能够在肠道黏膜定植,并能诱导强烈的免疫反应。其他研究也表明,它是一种递送异源抗原的高效活载体。在本文中,利用同源重组构建了一个胸苷酸合成酶基因(thyA)定义的突变体。除了在基本培养基中的形态变化和定植能力略有降低外,突变株IEM101-T在生长速率和免疫原性方面保持了野生型菌株IEM101的大部分理想特性。然而,该突变体比其亲本菌株具有更高的生物安全性。总之,IEM101-T可能是开发霍乱活疫苗候选株的有前景的菌株,或者是在体内递送异源抗原的有吸引力的疫苗载体。